Description
COVID longue
- Distinct brain alterations and neurodegenerative processes in cognitive impairment associated with post-acute sequelae of COVID-19on 5 Décembre 2025
Nat Commun. 2025 Nov 26;16(1):10552. doi: 10.1038/s41467-025-65597-z.ABSTRACTAlthough brain alterations have been reported in post-acute sequelae of SARS-CoV-2 (PASC), their prevalence and […]
- Post-COVID-19 condition patients' utilisation of healthcare resources after implementation of an integrated care uniton 5 Décembre 2025
Cost Eff Resour Alloc. 2025 Dec 2. doi: 10.1186/s12962-025-00667-z. Online ahead of print.NO ABSTRACTPMID:41331825 | DOI:10.1186/s12962-025-00667-z
- Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous diseaseon 5 Décembre 2025
Lancet Infect Dis. 2025 Nov 7:S1473-3099(25)00665-6. doi: 10.1016/S1473-3099(25)00665-6. Online ahead of print.NO ABSTRACTPMID:41213281 | DOI:10.1016/S1473-3099(25)00665-6
- Pursuing Reduction in Fatigue After COVID-19 via Exercise and Rehabilitation (PREFACER): a protocol for a randomised feasibility trialon 5 Décembre 2025
BMJ Open. 2025 Nov 9;15(11):e102112. doi: 10.1136/bmjopen-2025-102112.ABSTRACTINTRODUCTION: Over 777 million COVID-19 infections have occurred globally, with data suggesting that 10%-20% of those […]
- Resistance Exercise Therapy After COVID-19 Infection: A Randomized Clinical Trialon 5 Décembre 2025
JAMA Netw Open. 2025 Nov 3;8(11):e2534304. doi: 10.1001/jamanetworkopen.2025.34304.ABSTRACTIMPORTANCE: Long COVID presents an unmet therapeutic need.OBJECTIVE: To determine the effects of a […]
- Evaluation of Interventions for Cognitive Symptoms in Long COVID: A Randomized Clinical Trialon 5 Décembre 2025
JAMA Neurol. 2025 Nov 10. doi: 10.1001/jamaneurol.2025.4415. Online ahead of print.ABSTRACTIMPORTANCE: Treatment for cognitive dysfunction due to postacute sequelae of long COVID (ie, symptoms of […]
- A systematic review and meta-analysis of the impact of vaccination on prevention of long COVID - Natureon 5 Décembre 2025
A systematic review and meta-analysis of the impact of vaccination on prevention of long COVID Nature
- What Can We Learn Four Years On? A Multi-Centre Service Evaluation Exploring Symptoms, Functional Impact, Recovery and Care Pathways in Long Covidon 7 novembre 2025
Health Expect. 2025 Dec;28(6):e70435. doi: 10.1111/hex.70435.ABSTRACTBACKGROUND: Long Covid (LC) is associated with long-term health impacts that require ongoing support from healthcare services. We […]
- Clinical and cost-effectiveness of diverse posthospitalisation pathways for COVID-19: a UK evaluation using the PHOSP-COVID cohorton 7 novembre 2025
BMJ Open Respir Res. 2025 Oct 31;12(1):e003224. doi: 10.1136/bmjresp-2025-003224.ABSTRACTBACKGROUND: Long covid has emerged as a complex health condition for millions of people worldwide following […]
- Long COVID Trial Explores Anti-Inflammatory Treatmenton 7 novembre 2025
JAMA. 2025 Oct 31. doi: 10.1001/jama.2025.17537. Online ahead of print.NO ABSTRACTPMID:41171293 | DOI:10.1001/jama.2025.17537
- Physiotherapy interventions in post- and long-COVID-19: a scoping review of the literature up to February 2023on 7 novembre 2025
BMC Health Serv Res. 2025 Oct 30;25(1):1425. doi: 10.1186/s12913-025-13631-7.NO ABSTRACTPMID:41168795 | DOI:10.1186/s12913-025-13631-7
- Identifying Pediatric Long COVID: Comparing an EHR Algorithm to Manual Reviewon 7 novembre 2025
Appl Clin Inform. 2025 Oct;16(5):1445-1456. doi: 10.1055/a-2702-1574. Epub 2025 Oct 24.ABSTRACTLong COVID, characterized by persistent or recurring symptoms post-COVID-19 infection, poses challenges […]
- Children and young people with persistent post-COVID-19 condition over 24 months: a mixed-methods studyon 7 novembre 2025
BMJ Paediatr Open. 2025 Oct 21;9(1):e003634. doi: 10.1136/bmjpo-2025-003634.ABSTRACTPURPOSE: While most children and young people (CYP) recover from COVID-19, some develop 'post-COVID-19 condition' […]
- Persistent pain and brain fog after COVID-19 infection in European adults aged 50 and over: a population-based longitudinal studyon 7 novembre 2025
BMC Infect Dis. 2025 Oct 21;25(1):1366. doi: 10.1186/s12879-025-11761-1.ABSTRACTBACKGROUND: Psychological distress has been identified as a risk factor for long COVID in individuals infected with […]
- Applicability and adaptation of cognitive behavior therapy for long COVID neuropsychiatric symptoms: a review with insights from ME/CFSon 7 novembre 2025
BMC Infect Dis. 2025 Oct 10;25(1):1275. doi: 10.1186/s12879-025-11754-0.NO ABSTRACTPMID:41073921 | DOI:10.1186/s12879-025-11754-0
- Inflammatory predictors of Post-COVID fatigueon 7 novembre 2025
Brain Behav Immun Health. 2025 Sep 17;49:101109. doi: 10.1016/j.bbih.2025.101109. eCollection 2025 Nov.ABSTRACTThe biological mechanisms underlying objective and subjective fatigue in post-COVID […]
- Return to work with long COVID: a rapid review of support and challengeson 7 novembre 2025
BMJ Open. 2025 Oct 7;15(10):e101698. doi: 10.1136/bmjopen-2025-101698.ABSTRACTOBJECTIVES: To explore existing evidence for the provision of support for return to work (RTW) in long COVID (LC) […]
- Long COVID associated with SARS-CoV-2 reinfection among children and adolescents in the omicron era (RECOVER-EHR): a retrospective cohort studyon 6 octobre 2025
Lancet Infect Dis. 2025 Sep 30:S1473-3099(25)00476-1. doi: 10.1016/S1473-3099(25)00476-1. Online ahead of print.ABSTRACTBACKGROUND: Post-acute sequelae of SARS-CoV-2 infection (PASC) remain a major […]
- Long COVID exhibition co-produced with community opens at the Museum of Vancouver - Simon Fraser Universityon 6 octobre 2025
Long COVID exhibition co-produced with community opens at the Museum of Vancouver Simon Fraser University
- La COVID fait vieillir les vaisseaux sanguins des femmes, selon une étude - Radio-Canadaon 6 octobre 2025
La COVID fait vieillir les vaisseaux sanguins des femmes, selon une étude Radio-Canada
COVID longue : lignes directrices canadiennes
Mise à jour du 17 juillet 2025
Mise à jour du 31 mars 2025
Mise à jour du 5 mars 2025
Maladie de Lyme
- Quantifying the Public Health Impact of Lyme Disease in Minnesota: A Simulation Analysis of Reported and Unreported Caseson 5 Décembre 2025
J Health Econ Outcomes Res. 2025 Nov 20;12(2):221-228. doi: 10.36469/001c.146618. eCollection 2025.ABSTRACTBackground: Lyme disease, the most common vector-borne disease in Minnesota, is estimated to […]
- Polyvalent mRNA vaccine targeting outer surface protein C affords multi-strain protection against Lyme diseaseon 5 Décembre 2025
NPJ Vaccines. 2025 Dec 4. doi: 10.1038/s41541-025-01326-3. Online ahead of print.ABSTRACTThere is currently no Lyme disease (LD) vaccine available for use in humans. Outer surface protein C (OspC) of […]
- Genetic landscape of Borrelia burgdorferi sensu stricto in Canada: a study of genetic diversityon 5 Décembre 2025
Sci Rep. 2025 Nov 20;15(1):40954. doi: 10.1038/s41598-025-24758-2.ABSTRACTBorrelia burgdorferi sensu stricto (s.s.), the causative agent of Lyme disease in North America, exhibits considerable […]
- Guidelines for Lyme borreliosis: post-treatment Lyme disease syndrome (PTLDS)on 5 Décembre 2025
Infect Dis Now. 2025 Nov 26:105205. doi: 10.1016/j.idnow.2025.105205. Online ahead of print.ABSTRACTPersistent symptoms following appropriate treatment of confirmed Lyme borreliosis (LB) require a […]
- Risk Factors for Lyme Disease in the General Population-A Survey of Adults and Caregivers in 28 Stateson 5 Décembre 2025
Open Forum Infect Dis. 2025 Oct 21;12(11):ofaf658. doi: 10.1093/ofid/ofaf658. eCollection 2025 Nov.ABSTRACTBACKGROUND: There are an estimated 476 000 diagnosed and treated cases of Lyme disease (LD) […]
- Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosison 7 novembre 2025
Ger Med Sci. 2025 Oct 9;23:Doc13. doi: 10.3205/000349. eCollection 2025.ABSTRACTLyme disease is the most common tick-borne infectious disease in Europe. Neurological manifestations occur in 3-15% of […]
- Cutaneous Lyme borreliosis: Guideline of the German Dermatology Societyon 7 novembre 2025
Ger Med Sci. 2025 Oct 9;23:Doc12. doi: 10.3205/000348. eCollection 2025.ABSTRACTThe current S2k guideline "kutane Borreliose" has been updated in accordance with the methodological standards of the […]
- Identification of potential biomarkers for Lyme disease using bioinformatics and machine learningon 7 novembre 2025
Clin Exp Med. 2025 Oct 31;25(1):341. doi: 10.1007/s10238-025-01803-y.ABSTRACTLyme disease (LD) presents significant diagnostic challenges due to the absence of a reliable screening method for initial […]
- The diagnostic potential of proteomics and machine learning in Lyme neuroborreliosison 7 novembre 2025
Nat Commun. 2025 Oct 27;16(1):9322. doi: 10.1038/s41467-025-64903-z.ABSTRACTLyme neuroborreliosis (LNB), a nervous system infection caused by tick-borne spirochetes of the Borrelia burgdorferi sensu […]
- Late Lyme neuroborreliosis encephalomyelitis with distinct MRI features-a case report and systematic literature reviewon 7 novembre 2025
J Neurol. 2025 Oct 26;272(11):729. doi: 10.1007/s00415-025-13475-5.ABSTRACTBACKGROUND: Central nervous system (CNS) Lyme neuroborreliosis (LNB) rarely occurs. Clinical and radiological findings are […]
- Targeted volume imaging reveals early vascular interactions of Lyme disease pathogen in skinon 7 novembre 2025
Nat Commun. 2025 Oct 22;16(1):9330. doi: 10.1038/s41467-025-64326-w.ABSTRACTAlthough the contours of the dissemination pathways of human pathogenic spirochetes in the vertebrate hosts are known, […]
- Atypical facial oedema in acrodermatitis chronica atrophicans: A potential clue for early diagnosis in Lyme diseaseon 7 novembre 2025
Clin Exp Dermatol. 2025 Oct 11:llaf450. doi: 10.1093/ced/llaf450. Online ahead of print.NO ABSTRACTPMID:41074274 | DOI:10.1093/ced/llaf450
- The multiplexed single-tier InBios Lyme Detect Multiplex ELISA is more sensitive than standard two-tier tests in the early stages of Lyme diseaseon 7 novembre 2025
J Clin Microbiol. 2025 Oct 9:e0062925. doi: 10.1128/jcm.00629-25. Online ahead of print.ABSTRACTThere are nearly 500,000 cases of Lyme disease each year in the United States; 10%-20% of them result […]
- Transendothelial migration of the Lyme disease spirochete involves spirochete internalization as an intermediate step through a transcellular pathway that involves Cdc42 and Rac1 - PubMedon 6 octobre 2025
Despite its importance in pathogenesis, the hematogenous dissemination pathway of B. burgdorferi is still largely uncharacterized. To probe the molecular details of transendothelial migration more […]
- Excess Healthcare Costs and Resource Utilisation of Lyme Borreliosis in Germany: A Propensity Score-Matched Cohort Study - PubMedon 6 octobre 2025
Aim: Lyme borreliosis (LB) is the most common tick-borne disease in Germany; however, data on the economic burden of LB are limited. In this study, we aim to report healthcare costs, healthcare […]
- Identification of hub gene and immune infiltration in Lyme disease revealed by weighted gene co-expression network analysis and machine learningon 6 octobre 2025
Eur J Med Res. 2025 Sep 26;30(1):860. doi: 10.1186/s40001-025-03108-y.ABSTRACTINTRODUCTION: Lyme disease (LD), caused by the spirochete Borrelia burgdorferi (Bb), is a multisystem disorder with early […]
- Lyme borreliosis risk perceptions, disease knowledge, and training among at-risk groupson 6 octobre 2025
BMC Public Health. 2025 Sep 30;25(1):3160. doi: 10.1186/s12889-025-23604-4.ABSTRACTBACKGROUND: Lyme borreliosis (LB) is the most common tick-borne disease in Europe. Although there are indicators […]
- What Is Lyme Disease?on 6 octobre 2025
JAMA. 2025 Aug 25. doi: 10.1001/jama.2025.13708. Online ahead of print.NO ABSTRACTPMID:40853565 | DOI:10.1001/jama.2025.13708
- A novel single-tier serologic test to diagnose all stages of Lyme diseaseon 6 octobre 2025
J Clin Microbiol. 2025 Aug 20:e0048325. doi: 10.1128/jcm.00483-25. Online ahead of print.ABSTRACTLyme disease, a bacterial zoonosis, is the most commonly reported vector-borne disease in the United […]
- Cerebrospinal fluid protein profiling of inflammatory and neurobiological markers in Lyme neuroborreliosison 6 octobre 2025
Sci Rep. 2025 Jun 20;15(1):20190. doi: 10.1038/s41598-025-06146-y.ABSTRACTLyme neuroborreliosis (LNB) is the most common form of disseminated Lyme borreliosis in Europe and North America. There are […]
Encéphalomyélite myalgique
- Virus Genome Sequences in the Blood of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patientson 5 Décembre 2025
medRxiv [Preprint]. 2025 Nov 7:2025.11.06.25339689. doi: 10.1101/2025.11.06.25339689.ABSTRACTMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a baffling disease. The disease has a wide […]
- Integrated immune, hormonal, and transcriptomic profiling reveals sex-specific dysregulation in long COVID patients with ME/CFSon 5 Décembre 2025
Cell Rep Med. 2025 Nov 18;6(11):102449. doi: 10.1016/j.xcrm.2025.102449. Epub 2025 Nov 7.ABSTRACTLong COVID (LC) manifests with sex-specific differences, particularly in those with myalgic […]
- Contested and neglected: Social and medical marginalization in severe Chronic Fatigue Syndromeon 5 Décembre 2025
Soc Sci Med. 2025 Nov 8;388:118766. doi: 10.1016/j.socscimed.2025.118766. Online ahead of print.ABSTRACTThis study addresses the persistent invisibility of people with severe Myalgic […]
- Experiences and challenges of staying employed with chronic fatigue syndromeon 7 novembre 2025
Author Names: Surendran G.,Jose T.P. Database Source: Embase Daily Updates Journal Title: Discover public health Article […]
- A Perspective on the Role of Metformin in Treating Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long COVIDon 7 novembre 2025
ACS Pharmacol Transl Sci. 2025 Sep 11;8(10):3411-3431. doi: 10.1021/acsptsci.5c00229. eCollection 2025 Oct 10.ABSTRACTMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID (LC) […]
- Chronic Pain Prevalence, Characteristics, and Impact in United States Adults With Chronic Fatigue Syndrome/Myalgic Encephalomyelitison 7 novembre 2025
Pain Manag Nurs. 2025 Oct 30:S1524-9042(25)00291-7. doi: 10.1016/j.pmn.2025.10.006. Online ahead of print.ABSTRACTPURPOSE: To determine the prevalence of chronic pain, describe characteristics of […]
- Altered effort and deconditioning are not valid explanations of myalgic encephalomyelitis/chronic fatigue syndromeon 7 novembre 2025
Nat Commun. 2025 Oct 17;16(1):9176. doi: 10.1038/s41467-025-64538-0.NO ABSTRACTPMID:41107289 | DOI:10.1038/s41467-025-64538-0
- Understanding concussion in myalgic encephalomyelitis/chronic fatigue syndrome: Findings from the 2023 National Health Interview studyon 7 novembre 2025
Brain Inj. 2025 Oct 16:1-8. doi: 10.1080/02699052.2025.2575479. Online ahead of print.ABSTRACTBACKGROUND: Although myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) symptoms (dysautonomia, […]
- The association of fatigue and pain with cognitive test performance in patients with myalgic encephalomyelitis/chronic fatigue syndromeon 7 novembre 2025
J Psychosom Res. 2025 Oct 3;199:112401. doi: 10.1016/j.jpsychores.2025.112401. Online ahead of print.ABSTRACTOBJECTIVES: Patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) […]
- Corticosteroids with low glucocorticoid activity as a potential therapeutic strategy for post-COVID-19 myalgic encephalomyelitis/chronic fatigue syndrome in patients with bipolar affective disorder: A case reporton 7 novembre 2025
PCN Rep. 2025 Oct 12;4(4):e70222. doi: 10.1002/pcn5.70222. eCollection 2025 Dec.ABSTRACTBACKGROUND: The COVID-19 pandemic has led to an increase in post-acute sequelae, including myalgic […]
- Effects of recumbent isometric yoga on the daily functioning level of patients with myalgic encephalomyelitis/chronic fatigue syndrome: a randomized, controlled trialon 7 novembre 2025
Biopsychosoc Med. 2025 Oct 10;19(1):19. doi: 10.1186/s13030-025-00339-7.ABSTRACTBACKGROUND: Although seated isometric yoga has been shown to reduce the fatigue and pain of patients with myalgic […]
- First proposed blood test for chronic fatigue syndrome: what scientists thinkon 7 novembre 2025
Nature. 2025 Oct 9. doi: 10.1038/d41586-025-03299-8. Online ahead of print.NO ABSTRACTPMID:41068441 | DOI:10.1038/d41586-025-03299-8
- Systematic review: digital biomarkers of fatigue in chronic diseaseson 7 novembre 2025
NPJ Digit Med. 2025 Oct 8;8(1):602. doi: 10.1038/s41746-025-01939-x.ABSTRACTThis systematic review explores the relationship between digital biomarkers, measured using wearable devices, and fatigue […]
- Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Physical Fatigue Through the Perspective of Immunosenescenceon 6 octobre 2025
Compr Physiol. 2025 Oct;15(5):e70056. doi: 10.1002/cph4.70056.ABSTRACTBACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating illness marked by persistent fatigue, […]
- The gut microbial composition is different in chronic fatigue syndrome than in healthy controlson 6 octobre 2025
Sci Rep. 2025 Sep 26;15(1):33075. doi: 10.1038/s41598-025-16438-y.ABSTRACTThe pathogenesis of Chronic Fatigue Syndrome (CFS) is yet unknown. This study aimed to assess the gut microbial composition […]
- In transfusion-dependent thalassemia, neuronal damage biomarkers are associated with affective and chronic fatigue symptomson 6 octobre 2025
Sci Rep. 2025 Sep 24;15(1):32721. doi: 10.1038/s41598-025-16757-0.ABSTRACTPatients with transfusion-dependent thalassemia (TDT) are vulnerable to neurotoxicity due to frequent blood transfusions and […]
- Burden of Disease in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Scoping Reviewon 6 octobre 2025
Appl Health Econ Health Policy. 2025 Sep 23. doi: 10.1007/s40258-025-01006-2. Online ahead of print.ABSTRACTOBJECTIVE: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a serious chronic […]
- Advancing Digital Precision Medicine for Chronic Fatigue Syndrome through Longitudinal Large-Scale Multi-Modal Biological Omics Modeling with Machine Learning and Artificial Intelligenceon 6 octobre 2025
ArXiv [Preprint]. 2025 Jun 18:arXiv:2506.15761v1.ABSTRACTWe studied a generalized question: chronic diseases like ME/CFS and long COVID exhibit high heterogeneity with multifactorial etiology and […]
- Comorbidity of chronic pain and fatigue : Common mechanisms, common treatment steps?on 6 octobre 2025
Schmerz. 2025 Oct;39(5):322-328. doi: 10.1007/s00482-025-00898-2. Epub 2025 Aug 21.ABSTRACTFatigue and chronic pain show a high level of comorbidity and are both not only frequent symptoms of chronic […]
- Solriamfetol improves daily fatigue symptoms in adults with myalgic encephalomyelitis/chronic fatigue syndrome after 8 weeks of treatmenton 6 octobre 2025
J Psychopharmacol. 2025 Sep 16:2698811251368371. doi: 10.1177/02698811251368371. Online ahead of print.ABSTRACTBACKGROUND: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a long-term […]
Syndrome d'Ehlers-Danlos
- Comparative assessment of left common iliac vein compression in patients with hypermobile Ehlers-Danlos syndrome, hypermobility spectrum disorder and healthy controls - A retrospective single-centre studyon 5 Décembre 2025
Phlebology. 2025 Nov 17:2683555251400392. doi: 10.1177/02683555251400392. Online ahead of print.ABSTRACTObjectivesHeritable connective tissue disorders (HCTDs), including hypermobile Ehlers-Danlos […]
- Associations Between Pain and Substance Use Among Individuals Diagnosed with Ehlers-Danlos Syndromes or Generalized Hypermobility Spectrum Disorderon 5 Décembre 2025
Int J Behav Med. 2025 Nov 11. doi: 10.1007/s12529-025-10409-3. Online ahead of print.ABSTRACTBACKGROUND: Pain and substance use frequently co-occur. Research indicates pain motivates alcohol, […]
- Connective tissue changes in Ehlers-Danlos syndromes with and without axial spondyloarthropathyon 7 novembre 2025
J Ultrasound. 2025 Nov 4. doi: 10.1007/s40477-025-01092-x. Online ahead of print.ABSTRACTPURPOSE: Ehlers-Danlos Syndromes (EDS) are a group of connective tissue disorders characterized by joint […]
- Co-morbid monogenic disorders at chromosome region 1q2: LMNA- and FLG-related disorders in a patient referred for assessment of joint hypermobilityon 7 novembre 2025
Chromosome Res. 2025 Oct 30;33(1):24. doi: 10.1007/s10577-025-09785-z.ABSTRACTThe phenotypic similarities and genetic heterogeneity occurring in diverse forms of Ehlers Danlos Syndrome (EDS) subtypes […]
- Autonomic symptom burden, comorbidities and quality of life in women with Hypermobility Spectrum Disorders and hypermobile Ehlers-Danlos syndromeon 7 novembre 2025
Auton Neurosci. 2025 Oct 14;262:103356. doi: 10.1016/j.autneu.2025.103356. Online ahead of print.ABSTRACTBACKGROUND: Hypermobility Spectrum Disorders (HSD) and hypermobile Ehlers-Danlos syndrome […]
- Percutaneous transhepatic coil embolisation of a common hepatic artery aneurysm in vascular Ehlers-Danlos syndromeon 7 novembre 2025
CVIR Endovasc. 2025 Oct 16;8(1):85. doi: 10.1186/s42155-025-00600-8.ABSTRACTBACKGROUND: Vascular Ehlers-Danlos syndrome is a rare connective tissue disorder characterised by arterial fragility, […]
- Evidence of Altered Enteric Nervous System Structure Associated With Severe Dysmotility in a Patient With Ehlers-Danlos Syndromeon 6 octobre 2025
ACG Case Rep J. 2025 Sep 24;12(9):e01823. doi: 10.14309/crj.0000000000001823. eCollection 2025 Sep.ABSTRACTPatients with Ehlers-Danlos syndrome (EDS) suffer from gastroparesis, constipation, and gut […]
- Outcomes of revisional bariatric surgery in patient with hypermobile Ehlers-Danlos syndromeon 6 octobre 2025
J Surg Case Rep. 2025 Sep 30;2025(9):rjaf782. doi: 10.1093/jscr/rjaf782. eCollection 2025 Sep.ABSTRACTEhlers-Danlos syndrome (EDS), a rare group of inherited connective tissue disorders caused by […]
- Prevalence of Hypermobile Ehlers-Danlos Syndrome in Transgender and Gender Diverse Individuals: A Retrospective Cohort Studyon 6 octobre 2025
LGBT Health. 2025 Sep 23. doi: 10.1177/23258292251382250. Online ahead of print.ABSTRACTPurpose: This study compared the prevalence of hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility […]
- Varied Presentations of Arterial Events in Vascular Ehlers-Danlos Syndromeon 6 octobre 2025
JACC Case Rep. 2025 Sep 12:105424. doi: 10.1016/j.jaccas.2025.105424. Online ahead of print.ABSTRACTSpontaneous arterial aneurysms and dissections are relatively common in patients with vascular […]
- Ehlers-Danlos syndromes: Diagnosis and care pathway of these complex and multisystemic diseaseson 1 septembre 2025
Rev Med Interne. 2025 Aug 30:S0248-8663(25)00722-2. doi: 10.1016/j.revmed.2025.08.002. Online ahead of print.ABSTRACTEhlers-Danlos syndromes (EDS) are a heterogeneous group of rare and inherited […]
- A unique case of prenatal diagnosis of vascular Ehlers-Danlos syndromeon 1 septembre 2025
Int J Gynaecol Obstet. 2025 Aug 7. doi: 10.1002/ijgo.70431. Online ahead of print.ABSTRACTWe present a rare instance of prenatal diagnosis of vEDS without a family history. The suspicion of a genetic […]
- B3GALT6 mutations lead to compromised connective tissue biomechanics in Ehlers-Danlos syndromeon 1 septembre 2025
JCI Insight. 2025 Aug 22;10(16):e179474. doi: 10.1172/jci.insight.179474. eCollection 2025 Aug 22.ABSTRACTEhlers-Danlos syndromes (EDS) comprise a genetically and clinically heterogenous group of […]
- Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic Featureson 1 septembre 2025
Am J Med Open. 2025 Jul 18;14:100111. doi: 10.1016/j.ajmo.2025.100111. eCollection 2025 Dec.ABSTRACTBACKGROUND: Hypermobile Ehlers-Danlos syndrome (hEDS) affects multiple systems, but comprehensive […]
- Association Between Ehlers-Danlos Syndrome and Celiac Diseaseon 1 septembre 2025
Gastro Hep Adv. 2025 Jun 10;4(9):100719. doi: 10.1016/j.gastha.2025.100719. eCollection 2025.NO ABSTRACTPMID:40821885 | PMC:PMC12357298 | DOI:10.1016/j.gastha.2025.100719
- Navigating the psychosocial landscape of Ehlers-Danlos syndrome: an autobiographic case studyon 1 septembre 2025
Discov Ment Health. 2025 Aug 17;5(1):123. doi: 10.1007/s44192-025-00268-5.ABSTRACTLiving with a rare disorder, such as Ehlers-Danlos Syndrome (EDS), presents unique psychosocial challenges. This […]
- Health care supply in patients with Ehlers-Danlos syndromes and generalized hypermobility spectrum disorder: a German perspectiveon 1 septembre 2025
Orphanet J Rare Dis. 2025 Aug 16;20(1):436. doi: 10.1186/s13023-025-03937-4.ABSTRACTBACKGROUND: Diagnosing Ehlers-Danlos syndromes (EDS) and EDS-related "hypermobility spectrum disorder" (HSD) is […]
- Fragility in Focus: Gallbladder Rupture in a Patient With Vascular Ehlers-Danlos Syndromeon 1 septembre 2025
ANZ J Surg. 2025 Aug 15. doi: 10.1111/ans.70298. Online ahead of print.ABSTRACTSpontaneous lumenal haemorrhage in gallbladder with subsequent rupture in patient with vascular variant Ehlers-Danlos […]
- Vascular findings in five unrelated children with vascular Ehlers-Danlos syndrome: A multi-case reporton 1 septembre 2025
Eur J Med Genet. 2025 Aug 12:105035. doi: 10.1016/j.ejmg.2025.105035. Online ahead of print.ABSTRACTVascular Ehlers-Danlos syndrome (vEDS) is an inherited connective tissue disorder caused by […]
- Risk factors of patellofemoral instability in patients with hypermobile Ehlers-Danlos syndromeon 1 septembre 2025
Arch Orthop Trauma Surg. 2025 Aug 11;145(1):403. doi: 10.1007/s00402-025-06022-4.ABSTRACTPURPOSE: Hypermobile Ehlers-Danlos Syndrome (hEDS) is a connective tissue disorder characterized by joint […]
Études cliniques
- PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norwayon 5 Décembre 2025
Conditions: Post COVID-19 Condition, Unspecified; SARS-CoV2 Infection; COVID-19 Interventions: Drug: Nirmatrelvir/ritonavir; Drug: Placebo Sponsors: Haukeland University Hospital; University of […]
- Psychosomatic, Physical Activity or Both for Post-covid19 Syndromon 5 Décembre 2025
Conditions: Post-COVID-19 Syndrome Interventions: Behavioral: Exercise Therapy; Behavioral: Psychotherapy Sponsors: Hannover Medical School; Health Insurance Audi BKK; occupational health service […]
- Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional Capacityon 5 Décembre 2025
Conditions: Post-acute Sequelae of SARS-CoV-2 Infection Interventions: Behavioral: Exercise Sponsors: University of Colorado, Denver Recruiting
- Harnessing Optimism and Perseverance in the Face of Long COVID-Españolon 7 novembre 2025
Conditions: Post-Acute COVID-19 Syndrome Interventions: Behavioral: HOPE-LC~Espanol Sponsors: Icahn School of Medicine at Mount Sinai Not yet recruiting
- LIFT: Life Improvement Trialon 7 novembre 2025
Conditions: ME/CFS; Long COVID; PASC Interventions: Drug: Pyridostigmine; Drug: Low-Dose Naltrexone; Other: Placebo Sponsors: Brigham and Women's Hospital; Open Medicine Foundation Recruiting
- Development of Voice Biomarkers of Frequent COVID-19 and Long Covid-related Symptoms Based on Data From Users of the Long COVID Companion Appon 3 octobre 2025
Conditions: Long COVID Interventions: Other: No Intervention: Observational Cohort Sponsors: Luxembourg Institute of Health Not yet recruiting
- Complementary Self-help Strategies for Patients With Post-COVID-19 Syndromeon 3 octobre 2025
Conditions: Post-COVID-19 Syndrome Interventions: Behavioral: Complementary self-help strategies in addition to treatment as usual; Other: Treatment as usual Sponsors: Universität Duisburg-Essen […]
- Immunoadsorption vs. Sham Treatment in Post COVID-19 Patients With Chronic Fatigue Syndromeon 3 octobre 2025
Conditions: Fatigue; Post-Acute COVID-19 Syndrome Interventions: Procedure: Immunoadsorption vs. sham immunoadsorption Sponsors: Hannover Medical School Completed
- Chronic Stress as a Risk Factor for Long COVIDon 3 octobre 2025
Conditions: Long COVID; Acute COVID-19 Sponsors: Medical University of Graz; University of Klagenfurt; Wayne State University Completed
- Transcranial Ultrasound Stimulation for Cognitive Function Modulation in Patients With Post COVID-19 Brain Fogon 3 octobre 2025
Conditions: COVID-19; Brain Fog; Long COVID; Transcranial Ultrasound Stimulation Interventions: Device: sham transcranial ultrasound stimulation; Device: real transcranial ultrasound stimulation […]
- Visualizing Regional Lung Ventilation in Patients With Postacute-COVID-19on 3 octobre 2025
Conditions: Ventilatory Defect; COVID-19; Post-acute COVID-19 Syndrome; Electric Impedance Tomography; Post-COVID-19 Syndrome Sponsors: Jan-Christoph Lewejohann Completed
- Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndromeon 3 octobre 2025
Conditions: Post COVID-19 Syndrome Interventions: Biological: HB-adMSCs (allogeneic); Other: Placebo Sponsors: Hope Biosciences Research Foundation Completed
- Imbalances of Regional Pulmonary Ventilation in Patients With Post-acute-COVID-19on 3 octobre 2025
Conditions: COVID-19 Pneumonia; Post-acute COVID-19 Syndrome; Electric Impedance Interventions: Diagnostic Test: additional EIT Measurement Sponsors: Jan-Christoph Lewejohann Not yet recruiting
- Transcranial Pulse Stimulation (TPS) in Post-COVID-19on 3 octobre 2025
Conditions: Post-COVID-19 Syndrome; Fatigue Interventions: Device: Transcranial pulse stimulation Verum; Device: Transcranial pulse stimulation Sham Sponsors: Medical University of Vienna […]
- Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 Syndromeon 3 octobre 2025
Conditions: Post COVID-19 Syndrome Interventions: Biological: HB-adMSCs Sponsors: Hope Biosciences Research Foundation No longer available
- IMPACT-D+: Immune-Modulating and Psychometric Effects of Accelerated TMS in Depression Plus Comorbid Post-COVID-19 Conditionon 3 octobre 2025
Conditions: Depressive Disorder; Post-Acute COVID-19 Syndrome Interventions: Device: Intermittent theta-burst stimulation (iTBS) using PowerMAG 100 ppTMS Sponsors: Max-Planck-Institute of […]
- Characterization of the Immunometabolic Signature in Long COVID-19.on 3 octobre 2025
Conditions: Long COVID Interventions: Biological: Blood sample (at inclusion and 6 months later); Other: Patient questionnaires (at inclusion and 6 months later) Sponsors: University Hospital, […]
- Vagal Approaches on Long COVIDon 3 octobre 2025
Conditions: Long COVID Symptoms Interventions: Other: Sonocea Sonic Augmentation Technology (SAT); Other: Truvaga Electrical Vagus Nerve Stimulator Sponsors: Leidos Life Sciences Not yet recruiting
- Mechanism of Isolevuglandin-Protein Adduct Formation in Persistent Immune Activation in Long COVID POTSon 3 octobre 2025
Conditions: Post-Acute COVID-19 Syndrome; Postural Tachycardia Syndrome (POTS); SARS CoV 2 Infection; Long COVID19 Interventions: Drug: To Measure levels of circulating monocyte/ T cell doublets at […]
- CORona (COVID-19) Follow Up Study: Epidemiology, Pathophysiology, Prediction, and Communicationon 3 octobre 2025
Conditions: COVID-19; Long COVID; Post COVID-19 Condition Interventions: Other: no intervention, the CORFU study conducts analyses based on data which has been prospectively collected (and […]
Revue d'actualités
- Resistance Training Improves Long COVID Outcomeson 5 Décembre 2025
JAMA. 2025 Nov 21. doi: 10.1001/jama.2025.19746. Online ahead of print.NO ABSTRACTPMID:41269680 | DOI:10.1001/jama.2025.19746
- U of A research explores reasons for higher long-COVID rate among women - CTV Newson 5 Décembre 2025
U of A research explores reasons for higher long-COVID rate among women CTV News
- 8 trajectories for long COVID - Harvard Gazetteon 3 Décembre 2025
8 trajectories for long COVID Harvard Gazette
- Why women may experience long COVID at a higher rate than men - CTV Newson 3 Décembre 2025
Why women may experience long COVID at a higher rate than men CTV News
- Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease - The Lanceton 3 Décembre 2025
Negative results in long COVID clinical trials: choosing outcome measures for a heterogeneous disease The Lancet
- Valneva annonce des résultats finaux positifs de Phase 2 pour son candidat vaccin contre la maladie de Lyme - lesoleil.comon 3 Décembre 2025
Valneva annonce des résultats finaux positifs de Phase 2 pour son candidat vaccin contre la maladie de Lyme lesoleil.com
- Why is ‘chronic’ lyme disease so controversial? – podcaston 7 novembre 2025
- Long COVID is here to stay—even in children - The Lanceton 7 novembre 2025
Long COVID is here to stay—even in children The Lancet
- New research sheds light on why brain fog is a common symptom of long COVID. - Psychology Todayon 7 novembre 2025
New research sheds light on why brain fog is a common symptom of long COVID. Psychology Today
- Scientists may have discovered what’s behind long COVID-related brain fog - Toronto Staron 7 novembre 2025
Scientists may have discovered what’s behind long COVID-related brain fog Toronto Star
- Vivre avec la COVID longue : une exposition donne la parole aux malades - Radio-Canadaon 7 novembre 2025
Vivre avec la COVID longue : une exposition donne la parole aux malades Radio-Canada
- Enfin de l’espoir pour le syndrome de fatigue chronique - Le Devoiron 7 novembre 2025
Enfin de l’espoir pour le syndrome de fatigue chronique Le Devoir
- Lyme disease: 'My independence is gone completely' after tick bite - BBCon 6 octobre 2025
Lyme disease: 'My independence is gone completely' after tick bite BBC
- RFK Jr. nomme un chercheur controversé à la tête d’un comité sur la COVID longue - Radio-Canadaon 3 octobre 2025
RFK Jr. nomme un chercheur controversé à la tête d’un comité sur la COVID longue Radio-Canada
- Estrie | Une nouvelle fièvre transmise par une tique est recensée - La Presseon 1 septembre 2025
Estrie | Une nouvelle fièvre transmise par une tique est recensée La Presse
- Les dérives de la maladie de Lyme | Bonsoir bonsoir! - Radio-Canadaon 1 septembre 2025
Les dérives de la maladie de Lyme | Bonsoir bonsoir! Radio-Canada
- COVID longue et retour à la vie professionnelle : pas tout le monde est chanceux - Radio-Canadaon 10 juillet 2025
COVID longue et retour à la vie professionnelle : pas tout le monde est chanceux Radio-Canada
- COVID longue : fin d’un programme à l’Hôpital d’Ottawa - Radio-Canadaon 10 juillet 2025
COVID longue : fin d’un programme à l’Hôpital d’Ottawa Radio-Canada
- Santé Québec, symptôme d’incertitude pour les soins de COVID longue - Le Quotidienon 10 juillet 2025
Santé Québec, symptôme d’incertitude pour les soins de COVID longue Le Quotidien
- COVID longue: des tests à l'effort essentiels pour évaluer les séquelles cardiorespiratoires - ULaval nouvelleson 10 juillet 2025
COVID longue: des tests à l'effort essentiels pour évaluer les séquelles cardiorespiratoires ULaval nouvelles
Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.
Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.
Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.
|
Avis de non-responsabilité
Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit. Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.
Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées. Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.
Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42). Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité. Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables. |


